Solriamfetol's Effect on Cognitive Health in Apnea Participants During a Randomized Placebo-controlled Study
Status:
Recruiting
Trial end date:
2022-07-01
Target enrollment:
Participant gender:
Summary
The purpose of study JZP110-405 is to determine whether solriamfetol is effective at
improving cognitive function in participants with excessive daytime sleepiness (EDS)
associated with obstructive sleep apnea (OSA).